Cargando…
Nonalcoholic Fatty Liver Disease as an Emerging Risk Factor and Potential Intervention Target for Atherosclerotic Cardiovascular Diseases
Nonalcoholic fatty liver disease (NAFLD) is an underappreciated independent risk factor for atherosclerotic cardiovascular diseases (ASCVDs). In recent years, the risk of ASCVD has increased along with the prevalence of NAFLD. ASCVD events are highly prevalent and are the main contributor to death i...
Autores principales: | Zhang, Daqing, Mi, Zhen, Peng, Jiya, Yang, Tiangui, Han, Yuze, Zhai, Yujia, Song, Chenliang, Teng, Xianzhuo, Sun, Wei, Guo, Jing, Bilonda, Kabeya Paulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155697/ https://www.ncbi.nlm.nih.gov/pubmed/36917556 http://dx.doi.org/10.1097/FJC.0000000000001418 |
Ejemplares similares
-
Elevated postprandial triglyceride-rich lipoproteins in patients with diabetes and stable coronary artery disease correlated with early renal damage and systemic inflammation
por: Guo, Xu, et al.
Publicado: (2023) -
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023) -
Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease
por: Golabi, Pegah, et al.
Publicado: (2019) -
Evaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease
por: Mohammadi, Afshin, et al.
Publicado: (2011) -
Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events
por: Wu, Liang, et al.
Publicado: (2020)